# AYALA PHARMACEUTICALS INC (AYLA)

> Institutional ownership reported to the SEC as of Q4 2022, from Form 13F filings. Source: https://holderbook.com/stocks/AYLA/

- Reporting holders: 11
- Reported value: $946.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Harel Insurance Investments & Financial Services Ltd.](https://holderbook.com/funds/1429390-harel-insurance-investments-financial-services-ltd/) | $862.0K | 2,153,273 | 0.0% | 7 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1107261-bridgeway-capital-management-llc/) | $23.9K | 56,900 | 0.0% | 8 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $21.0K | 53,600 | 0.0% | 3 |
| [Psagot Value Holdings Ltd. / (Israel)](https://holderbook.com/funds/1912576-psagot-value-holdings-ltd-israel/) | $14.0K | 36,232 | 0.0% | 2 |
| [TWO SIGMA SECURITIES, LLC](https://holderbook.com/funds/1450144-two-sigma-securities-llc/) | $6.4K | 16,063 | 0.0% | 2 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $5.6K | 13,931 | 0.0% | 2 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $4.8K | 11,415 | 0.0% | 1 |
| [Avantax Planning Partners, Inc.](https://holderbook.com/funds/1005441-avantax-planning-partners-inc/) | $4.0K | 10,000 | 0.0% | 1 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $4.0K | 10,596 | 0.0% | 4 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $404 | 1,010 | 0.0% | 1 |
| [Ameliora Wealth Management Ltd.](https://holderbook.com/funds/1910168-ameliora-wealth-management-ltd/) | $316 | 750 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2022 | 11 | $946.5K |
| Q3 2022 | 14 | $2.6M |
| Q2 2022 | 13 | $4.6M |
| Q1 2022 | 14 | $18.8M |
| Q4 2021 | 13 | $41.7M |
| Q3 2021 | 13 | $30.6M |
| Q2 2021 | 12 | $20.9M |
| Q1 2021 | 11 | $22.3M |
| Q4 2020 | 7 | $19.4M |
| Q3 2020 | 7 | $19.2M |
| Q2 2020 | 7 | $17.9M |